Gene Query: AEN

Dataset Description Geneva Score
RNA-seq analysis to identify the genes regulated by p53-SET interplay 73.9
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 65.88
Gene expression in PANC1 cells treated with Rakicidin 59.8
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 59.75
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 57.83
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 50.0
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 44.93
Tracking of dCas9-methyltransferase footprints 44.84
R430: A potent inbibitor of DNA and RNA viruses 43.84
RNA-seq in transgenic cells 43.21
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 43.02
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 42.25
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 41.66
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 41.19
Transcriptome analysis in Neobractatin treated cells 40.49
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 38.56
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 38.56
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 36.52
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 36.46
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 36.38
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 36.25
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 34.74
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 34.66
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 34.54
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 33.41
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 33.41
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 33.08
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 32.61
Active translatome profiling with RiboLace in MCF7 cells 31.79
LncRNA-GAS5 negative regulation of YAP-target genes expression 30.35
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 30.3
A transcriptome-wide divergence in protein translation scales with LIN28B expression 28.24
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 27.14
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 26.99
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 26.23
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 25.88
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 25.8
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 25.62
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 25.58
Ebola virus (EBOV) infection of ARPE-19 cells 25.5
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 25.23
NR2F2 study 25.23
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 25.15
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 24.79
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 24.58
Genome-wide transcriptional response to random aneuploidy in human cells 24.58
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 23.35
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 23.24
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 23.22
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 23.13
High level DNA repair gene expression in human ES cells 23.04
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 22.86
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 22.47
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 22.4
Primary human trophoblast from term placenta 22.29
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 22.12
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 22.01
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 22.01
4sU-seq of HFF exposed to salt and heat stress 21.88
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 21.85
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 21.81
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 21.62
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 21.33
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 21.24
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 20.93
Identification of HOXB13 target genes responsive to BET inhibitors 20.82
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 20.81
RNA transcriptome analysis during HSV-1 infection 20.7
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 20.44
JunB control of keratinocyte-mediated inflammation [RNA-seq] 20.37
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 20.37
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 20.34
Knockdown of ADNP in HCT116 colon cancer cells 20.08
SETBP1-WT and SETBP1-G870S epigenetic landscapes 19.93
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 19.93
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 19.93
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  19.61
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 19.55
Transcriptome analysis of H9 hESC derived cerebral organoids 19.54
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 19.51
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 19.43
Effect of ILF3 on translation during homeostasis and the antiviral response 19.38
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 19.31
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 19.05
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 19.04
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 18.86
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 18.74
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 18.67
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 18.44
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 18.44
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 18.37
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 18.31
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 18.31
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 18.16
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 18.03
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 17.93
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 17.93
X-Ray induced DNA-Hydroxymethylation changes 17.87
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 17.85
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 17.54
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 17.52
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 17.52
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 17.32
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 17.32
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 17.28
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 17.25
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 17.23
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 17.01
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 16.98
FBXW7 modulates stress response by post-translational modification of HSF1 16.98
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 16.93
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 16.93
RNAseq Analysis in glioblastoma cells treated with Mepazine 16.85
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 16.82
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 16.82
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 16.75
Identification of Sin3B regulated genes during quiescence 16.73
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 16.7
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 16.67
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 16.61
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 16.59
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 16.45
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 16.45
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 16.31
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 16.3
RNAseq Study in CC-671 Treated Cal-51 Cells 16.03
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 15.97
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 15.97
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 15.92
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 15.87
Genetic-to-epigenetic Therapy for Pancreatic Cancer 15.82
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 15.81
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 15.68
ETV7 and interferon response 15.66
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 15.66
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 15.63
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 15.63
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 15.62
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 15.62
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 15.57
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 15.56
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 15.55
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 15.54
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 15.54
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 15.51
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 15.39
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 15.23
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 15.17
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 15.11
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 15.01
Zika infected neural stem cells 14.87
Transcriptome analysis of Zika infected neural stem cells 14.87
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 14.85
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 14.78
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 14.77
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 14.75
Uridylation by TUT4 and TUT7 marks mRNA for degradation 14.72
Role of COP1 on MAP kinase transcriptional output in melanoma 14.71
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 14.53
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 14.52
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 14.52
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 14.52
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 14.43
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 14.43
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 14.43
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 14.32
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 14.13
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 14.09
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 14.09
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 14.02
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 14.02
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 13.96
Genome-wide analysis of Dengue virus 2 infected cells 13.95
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 13.89
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 13.89
Functional role of SLIT2 and ROBO1 in trophoblasts 13.61
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.6
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 13.6
RNA sequencing of GlyH-101-treated MCF-7 cell line 13.52
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 13.51
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 13.47
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 13.42
Total RNA-seq in ALL-SIL upon JQ1 inhibition 13.41
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 13.41
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 13.41
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 13.39
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 13.34
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 13.3
Systematic discovery of endogenous human ribonucleoprotein complexes 13.18
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 13.17
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 13.14
CD95/Fas ligand mRNA is toxic to cells 13.13
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 13.12
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 13.07
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 13.07
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 13.02
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 13.02
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 13.01
Cerebellar differentiation in Ataxia-Telangiectasia 12.94
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 12.94
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 12.94
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 12.94
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 12.94
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 12.84
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 12.8
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 12.69
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 12.69
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 12.63
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 12.57
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 12.57
Regulation of protein translation during mitosis 12.48
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 12.48
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 12.48
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 12.4
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 12.4
TFAP2C signalling in human fibroblasts 12.38
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 12.37
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 12.26
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 12.21
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 12.16
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 12.15
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 12.15
RNA-seq analysis of uveal melanoma cells treated with FR900359 12.14
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 12.13
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 12.13
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 12.1
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 11.99
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 11.98
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 11.97
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 11.92
Hypoxic transcriptome of SQ20B human head and neck cancer cells 11.89
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 11.88
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 11.86
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.84
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 11.84
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 11.83
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 11.8
Lysine benzoylation is a novel histone mark [RNA-seq] 11.68
Lysine benzoylation is a novel histone mark 11.68
BASP1 modifies the Tamoxifen response 11.66
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 11.65
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.62
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 11.62
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 11.6
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 11.6
Ectoderm specification of H1 human embryonic stem cells 11.52
Effect of drugs on transcriptomic profiles 11.52
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 11.46
Controlling for gene expression changes in transcription factor protein networks. 11.27
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 11.26
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 11.23
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 11.22
Examining serotonergic neuron differentiation from human iPSCs 11.22
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 11.19
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.18
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.15
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 11.14
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 11.12
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 11.11
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 11.08
UV_24h_GRO-Seq 10.97
Global gene expression profile of dasatinib-resistant RCH-ACV cells 10.95
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 10.91
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.6
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 10.59
RNA-seq analyisis of PUM2 knockout cells 10.58
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 10.54
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 10.54
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 10.54
Downregulation of DDX5/DDX17 and REST 10.46
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 10.44
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 10.41
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 10.37
Transcriptome analysis of SKI knock-out in HL60 cells 10.37
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 10.29
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 10.22
Regulating Interleukin-2 activity with engineered receptor signaling clamps 10.16
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 10.15
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 10.14
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 10.13
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 10.13
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 10.05
Endothelial gene expression analysis 10.05
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 10.03
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 10.0
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.0
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 9.97
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 9.94
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 9.94
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 9.85
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 9.84
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 9.84
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 9.81
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 9.8
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 9.79
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 9.73
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 9.73
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 9.66
RNA-seq of MDA-MB-231 cells with TET1 knockout 9.61
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.57
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 9.56
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 9.54
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 9.41
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 9.35
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 9.34
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 9.32
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 9.28
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 9.25
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 9.21
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 9.21
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 9.2
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 9.2
Illumina Total RNA-seq in HeLa 9.15
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 9.12
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 9.11
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 9.04
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 9.04
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 9.04
Cajal bodies are linked to genome conformation [RNA-Seq] 9.03
Cajal bodies are linked to genome conformation 9.03
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 8.99
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 8.99
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 8.9
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 8.81
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 8.81
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.8
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 8.78
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 8.77
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.73
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 8.7
Dynamic reorganization of nuclear architecture during human cardiogenesis 8.7
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.69
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 8.56
Expression profiling of converted and control dermal BJ fibroblasts 8.56
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 8.53
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.42
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 8.31
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.27
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 8.26
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 8.18
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.15
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.15
RNA Seq of HMVEC under hypoxia 8.12
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.12
A549 cell transcriptome responses to infection with H7N9 influenza virus 8.08
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 8.07
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 8.07
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 7.98
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 7.98
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 7.83
Silencing SPIB in attached and floating state of H1703 lung cancer cells 7.8
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 7.79
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 7.75
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 7.73
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 7.72
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 7.7
MeRIP-seq for heat shock in B-cell lymphoma cells 7.68
Total RNA-Seq data from leukemic patients with complex structural variants 7.45
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 7.43
SRSF1 role in cellular gene expression and splicing 7.34
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.34
Determining mRNA half-lives on a transcriptome-wide scale 7.33
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 7.31
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.3
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.3
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 7.22
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.19
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 7.16
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 7.16
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 7.13
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 7.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 6.98
Cell responses to dysregulated VZV-induced cell-cell fusion 6.95
ARID1A and ARID1B loss in HCT116 cells 6.84
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 6.78
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 6.68
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 6.67
FGF2 regulation of gene expression in stable inducible Neurons 6.66
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 6.54
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 6.51
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.47
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 6.45
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 6.38
RNA-sequencing in immortalized human mammary epithelial cells 6.38
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 6.26
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 5.95
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 5.95
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 5.95
CD73 knockdown effect in pancreatic cancer cell lines 5.84
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.77
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 5.56
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 5.53
Studying the selectivity of a small molecule Synucleozid on transcriptome 5.51
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 5.42
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 5.41
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 5.33
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 5.19
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 5.15
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 5.15
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 5.14
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 5.14
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 5.14
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 5.04
RNA seq with AML (NB4) cells upon FTO inhibition 4.99
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.99
Genome-wide analysis of the Integrator complex 4.96
Genome-wide analysis of the Integrator complex (HTS) 4.96
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.82
HNRNPM-regulated splicing dependencies in prostate cancer 4.79
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 4.79
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.67
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.62
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.62
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 4.59
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 4.54
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 4.49
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.47
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.39
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 4.39
Effect of from Human Umbilical Vein Endothelial Cells 4.37
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.36
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 4.36
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 4.31
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 4.14
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.99
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 3.97
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 3.91
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.91
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.9
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 3.78
Gene expressions of H9s in different culture systems 3.77
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 3.57
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.55
Disruption of GRIN2B impairs differentiation in human neurons 3.52
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 3.39
CSL RNA-Seq on HKC and SCC cell lines 3.37
CSL 3.37
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.36
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.36
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 3.27
Activity-dependent transcriptional changes in human neurons 3.27
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 3.2
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.11
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.99
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.82
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.82
RNA-seq analysis of BAP1-depleted uveal melanoma cells 2.79
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.76
Novel Targeting of Transcription and Metabolism in Glioblastoma 2.66
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.66
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.66
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 2.63
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 2.62
RNA Sequencing of Human iPS derived Cardiomyocytes 2.53
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.4
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 2.36
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 2.16
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.12
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 2.08
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 2.0
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.94
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.94
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.68
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.67
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 1.67
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 1.65
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 1.65
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.52
The DPYSL2 gene connects mTOR and schizophrenia 1.44
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 1.42
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 1.4
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.28
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.24
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 1.22
Myc activation coordinates gene transcription and protein translation responses 1.22
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.19
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 1.19
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.19
Identification of global XBP1s target gene expression in human prostate cancer cells 1.12
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.11
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.0
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.96
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.84
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.83
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.78
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.62
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.61
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.61
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 0.54
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.52
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 0.5
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.48
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.47
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.44
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.25
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.22
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.15
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.13
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.12
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.05


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation